Acyclovir Dosing for Disseminated VZV and HSV
For disseminated HSV: use acyclovir 10 mg/kg IV every 8 hours for 21 days in children and adults; for neonatal disseminated HSV: use 20 mg/kg IV every 8 hours for 21 days. For disseminated VZV: use acyclovir 10 mg/kg IV every 8 hours (or 500 mg/m² every 8 hours in children) for 7-10 days, with consideration for 10-15 mg/kg every 8 hours in severe cases.
HSV Dosing by Age and Disease Severity
Neonatal HSV (Birth to 1 month)
- Disseminated or CNS disease: Acyclovir 20 mg/kg IV every 8 hours for 21 days 1, 2
- Critical point: Do not discontinue therapy until repeat CSF HSV DNA PCR is negative at days 19-21 of treatment 2
- Skin, eye, or mouth disease only: Acyclovir 20 mg/kg IV every 8 hours for 14 days 1
Children and Adults (Beyond Neonatal Period)
- CNS or disseminated HSV disease: Acyclovir 10 mg/kg IV every 8 hours for 21 days 1, 2
- Alternative dosing in children >1 year: 500 mg/m² IV every 8 hours 1
- Moderate to severe mucocutaneous disease: Acyclovir 5-10 mg/kg IV every 8 hours, then switch to oral when lesions regress 1
The evidence strongly supports these dosing regimens, with landmark trials demonstrating that acyclovir reduces mortality in HSV encephalitis from 70% to 20-30% 3. However, outcomes remain poor with delays >48 hours between admission and treatment initiation 3.
VZV Dosing by Patient Population
Immunocompromised Patients with Disseminated VZV
- Standard dose: Acyclovir 10 mg/kg IV every 8 hours for 7-10 days 4
- Alternative pediatric dosing: 500 mg/m² IV every 8 hours for 7-10 days 1, 5
- Higher dose consideration: 10-15 mg/kg IV every 8 hours if renal function permits 4
The rationale for potentially higher dosing stems from VZV being less sensitive to acyclovir than HSV 4, 6. Most clinicians use the 10 mg/kg dose due to nephrotoxicity concerns, but 15 mg/kg can be considered in severe cases with normal renal function and close monitoring 4.
VZV Encephalitis
- Acyclovir 10 mg/kg IV every 8 hours for up to 14 days 4
- Consider adding corticosteroids (e.g., prednisolone 60-80 mg daily for 3-5 days) due to inflammatory pathogenesis 4
- Immunocompromised patients may require prolonged courses 4
Pediatric VZV Dosing (Encephalitis)
- Ages 3 months-12 years: 500 mg/m² IV every 8 hours 3
- Ages >12 years: 10 mg/kg IV every 8 hours 3
- Start within 6 hours of admission if encephalitis suspected 3
Critical Safety Considerations
Renal Toxicity Prevention
Acyclovir crystalluria and obstructive nephropathy occur in up to 20% of patients, typically after 4 days of IV therapy 3. Essential precautions:
- Maintain adequate hydration throughout treatment 3
- Infuse over 1 hour minimum (never bolus) 7
- Monitor renal function closely 3
- Adjust dose for creatinine clearance <50 mL/min 7
Neurologic Monitoring
Approximately 1% of patients develop encephalopathic changes (lethargy, confusion, seizures, coma) 7. Use caution in patients with:
- Pre-existing neurologic abnormalities
- Severe renal or hepatic impairment
- Significant hypoxia 7
Treatment Duration Nuances
For HSV encephalitis in children ages 3 months-12 years, minimum 21 days of acyclovir is recommended before considering stopping, as relapse rates may reach 26-29% with shorter courses 3. Some experts advocate repeating CSF HSV PCR at 14-21 days and continuing treatment until negative 3.
For disseminated VZV, the standard 7-10 day course is typically adequate 1, 8, 5, though immunocompromised patients may require longer treatment based on clinical response 4.
Acyclovir-Resistant Disease
If patients fail to respond to standard acyclovir therapy:
- Foscarnet: 40 mg/kg IV every 8 hours or 60 mg/kg IV every 12 hours 1
- Consider resistance testing, particularly in immunocompromised patients with prolonged exposure 7, 9
The evidence base for these dosing recommendations is robust, derived from multiple randomized controlled trials 7, 8, 5 and supported by comprehensive guidelines from CDC, NIH, IDSA, and British neurological societies 1, 3, 4, 3.